Cargando…

Lack of a Clear Behavioral Phenotype in an Inducible FXTAS Mouse Model Despite the Presence of Neuronal FMRpolyG-Positive Aggregates

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a rare neurodegenerative disorder caused by a 55–200 CGG repeat expansion in the 5′ untranslated region of the Fragile X Mental Retardation 1 (FMR1) gene. FXTAS is characterized by progressive cerebellar ataxia, Parkinsonism, intention tremors a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haify, Saif N., Mankoe, Ruchira S. D., Boumeester, Valerie, van der Toorn, Esmay C., Verhagen, Rob F. M., Willemsen, Rob, Hukema, Renate K., Bosman, Laurens W. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768028/ https://www.ncbi.nlm.nih.gov/pubmed/33381520 http://dx.doi.org/10.3389/fmolb.2020.599101

Ejemplares similares

Small molecule 1a reduces FMRpolyG-mediated toxicity in in vitro and in vivo models for FMR1 premutation
por: Haify, Saif N, et al.
Publicado: (2021)

FMRpolyG-positive inclusions in CNS and non-CNS organs of a fragile X premutation carrier with fragile X-associated tremor/ataxia syndrome
por: Buijsen, Ronald AM, et al.
Publicado: (2014)

Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome
por: Sellier, Chantal, et al.
Publicado: (2017)

FMRpolyG accumulates in FMR1 premutation granulosa cells
por: Friedman-Gohas, M., et al.
Publicado: (2020)

Inducible expression of human C9ORF72 36× G(4)C(2) hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice
por: Riemslagh, Fréderike W., et al.
Publicado: (2021)

In silico, in vitro, and in vivo Approaches to Identify Molecular Players in Fragile X Tremor and Ataxia Syndrome
por: Haify, Saif N., et al.
Publicado: (2020)

Expression of FMRpolyG in Peripheral Blood Mononuclear Cells of Women with Fragile X Mental Retardation 1 Gene Premutation
por: Nguyen, Xuan Phuoc, et al.
Publicado: (2022)

Intracellular FMRpolyG-Hsp70 complex in fibroblast cells from a patient affected by fragile X tremor ataxia syndrome
por: Bonapace, Giuseppe, et al.
Publicado: (2019)

CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor/ataxia syndrome
por: Asamitsu, Sefan, et al.
Publicado: (2021)

Editorial: Proceedings of the “Fourth International Conference of the FMR1 Premutation: Basic Mechanisms, Clinical Involvement and Therapy”
por: Usdin, Karen, et al.
Publicado: (2021)

Astroglial-targeted expression of the fragile X CGG repeat premutation in mice yields RAN translation, motor deficits and possible evidence for cell-to-cell propagation of FXTAS pathology
por: Wenzel, H. Jürgen, et al.
Publicado: (2019)

Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS
por: Drozd, Malgorzata, et al.
Publicado: (2019)

The FMRpolyGlycine Protein Mediates Aggregate Formation and Toxicity Independent of the CGG mRNA Hairpin in a Cellular Model for FXTAS
por: Hoem, Gry, et al.
Publicado: (2019)

Neuropathology of FMR1-premutation carriers presenting with dementia and neuropsychiatric symptoms
por: Dijkstra, Anke A, et al.
Publicado: (2021)

Emerging topics in FXTAS
por: Hall, Deborah A, et al.
Publicado: (2014)

Combination Therapy in Fragile X Syndrome; Possibilities and Pitfalls Illustrated by Targeting the mGluR5 and GABA Pathway Simultaneously
por: Zeidler, Shimriet, et al.
Publicado: (2017)

Erratum: Emerging topics in FXTAS
por: Hall, Deborah A, et al.
Publicado: (2015)

Reduction of oxidative stress suppresses poly-GR-mediated toxicity in zebrafish embryos
por: Riemslagh, Fréderike W., et al.
Publicado: (2021)

Current Gaps in Understanding the Molecular Basis of FXTAS
por: Hagerman, Paul J.
Publicado: (2012)

A Chinese case of fragile X-associated tremor/ataxia syndrome (FXTAS) with orthostatic tremor:case report and literature review on tremor in FXTAS
por: Zhao, Cuiping, et al.
Publicado: (2020)

Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers
por: Al Olaby, Reem R., et al.
Publicado: (2018)

Acute Stroke in Middle Cerebellar Peduncle in a Patient With FXTAS
por: Hall, Deborah A., et al.
Publicado: (2018)

Middle Cerebellar Peduncle Width—A Novel MRI Biomarker for FXTAS?
por: Shelton, Annie L., et al.
Publicado: (2018)

Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism
por: Wang, Xiao-Hong, et al.
Publicado: (2018)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
por: Aydin, Elber Yuksel, et al.
Publicado: (2020)

Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
por: Salcedo-Arellano, Maria Jimena, et al.
Publicado: (2023)

Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI)
por: Sherman, Stephanie L, et al.
Publicado: (2014)

Low Diversity of Human Variation Despite Mostly Mild Functional Impact of De Novo Variants
por: Mahlich, Yannick, et al.
Publicado: (2021)

New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype
por: Fraint, Avram, et al.
Publicado: (2014)

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications
por: Cabal-Herrera, Ana Maria, et al.
Publicado: (2020)

Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): A Gender Perspective
por: Orsucci, Daniele, et al.
Publicado: (2022)

BC RNA Mislocalization in the Fragile X Premutation
por: Muslimov, Ilham A., et al.
Publicado: (2018)

Routine Optical Clearing of 3D-Cell Cultures: Simplicity Forward
por: Nürnberg, Elina, et al.
Publicado: (2020)

Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
por: Hagerman, Randi J, et al.
Publicado: (2008)

Targeting the r(CGG) Repeats That Cause FXTAS with Modularly Assembled Small Molecules and Oligonucleotides
por: Tran, Tuan, et al.
Publicado: (2014)

Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

Concomitant occurrence of FXTAS and clinically defined sporadic inclusion body myositis: report of two cases
por: Lechpammer, Mirna, et al.
Publicado: (2017)

Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series
por: Salcedo-Arellano, Maria Jimena, et al.
Publicado: (2020)

Metabolomic Biomarkers Are Associated With Area of the Pons in Fragile X Premutation Carriers at Risk for Developing FXTAS
por: Zafarullah, Marwa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vhj1uv6h7chhg4821asuam43gv